1034 related articles for article (PubMed ID: 17519314)
1. Serum sex hormone-binding globulin levels in healthy children and girls with precocious puberty before and during gonadotropin-releasing hormone agonist treatment.
Sørensen K; Andersson AM; Skakkebaek NE; Juul A
J Clin Endocrinol Metab; 2007 Aug; 92(8):3189-96. PubMed ID: 17519314
[TBL] [Abstract][Full Text] [Related]
2. Serum levels of growth hormone binding protein in children with normal and precocious puberty: relation to age, gender, body composition and gonadal steroids.
Juul A; Fisker S; Scheike T; Hertel T; Müller J; Orskov H; Skakkebaek NE
Clin Endocrinol (Oxf); 2000 Feb; 52(2):165-72. PubMed ID: 10671943
[TBL] [Abstract][Full Text] [Related]
3. Serum insulin-like growth factor I (IGF-I) and IGF-binding protein 3 levels are increased in central precocious puberty: effects of two different treatment regimens with gonadotropin-releasing hormone agonists, without or in combination with an antiandrogen (cyproterone acetate).
Juul A; Scheike T; Nielsen CT; Krabbe S; Müller J; Skakkebaek NE
J Clin Endocrinol Metab; 1995 Oct; 80(10):3059-67. PubMed ID: 7559897
[TBL] [Abstract][Full Text] [Related]
4. Use of a potent, long acting agonist of gonadotropin-releasing hormone in the treatment of precocious puberty.
Boepple PA; Mansfield MJ; Wierman ME; Rudlin CR; Bode HH; Crigler JF; Crawford JD; Crowley WF
Endocr Rev; 1986 Feb; 7(1):24-33. PubMed ID: 2937629
[TBL] [Abstract][Full Text] [Related]
5. Somatomedin-C in normal puberty and in true precocious puberty before and after treatment with a potent luteinizing hormone-releasing hormone agonist.
Harris DA; Van Vliet G; Egli CA; Grumbach MM; Kaplan SL; Styne DM; Vainsel M
J Clin Endocrinol Metab; 1985 Jul; 61(1):152-9. PubMed ID: 3889035
[TBL] [Abstract][Full Text] [Related]
6. Is obesity an outcome of gonadotropin-releasing hormone agonist administration? Analysis of growth and body composition in 110 patients with central precocious puberty.
Palmert MR; Mansfield MJ; Crowley WF; Crigler JF; Crawford JD; Boepple PA
J Clin Endocrinol Metab; 1999 Dec; 84(12):4480-8. PubMed ID: 10599706
[TBL] [Abstract][Full Text] [Related]
7. Adiposity, chronic inflammation, and the prepubertal decline of sex hormone binding globulin in children: evidence for associations with the timing of puberty (Earlybird 58).
Pinkney J; Streeter A; Hosking J; Mostazir M; Jeffery A; Wilkin T
J Clin Endocrinol Metab; 2014 Sep; 99(9):3224-32. PubMed ID: 24926948
[TBL] [Abstract][Full Text] [Related]
8. Insulin sensitivity and lipid profiles in girls with central precocious puberty before and during gonadal suppression.
Sørensen K; Mouritsen A; Mogensen SS; Aksglaede L; Juul A
J Clin Endocrinol Metab; 2010 Aug; 95(8):3736-44. PubMed ID: 20484471
[TBL] [Abstract][Full Text] [Related]
9. A randomized controlled trial of three years growth hormone and gonadotropin-releasing hormone agonist treatment in children with idiopathic short stature and intrauterine growth retardation.
Kamp GA; Mul D; Waelkens JJ; Jansen M; Delemarre-van de Waal HA; Verhoeven-Wind L; Frölich M; Oostdijk W; Wit JM
J Clin Endocrinol Metab; 2001 Jul; 86(7):2969-75. PubMed ID: 11443153
[TBL] [Abstract][Full Text] [Related]
10. Changes in growth and serum growth hormone and plasma somatomedin-C levels during suppression of gonadal sex steroid secretion in girls with central precocious puberty.
Mansfield MJ; Rudlin CR; Crigler JF; Karol KA; Crawford JD; Boepple PA; Crowley WF
J Clin Endocrinol Metab; 1988 Jan; 66(1):3-9. PubMed ID: 2961786
[TBL] [Abstract][Full Text] [Related]
11. Reproductive axis after discontinuation of gonadotropin-releasing hormone analog treatment of girls with precocious puberty: long term follow-up comparing girls with hypothalamic hamartoma to those with idiopathic precocious puberty.
Feuillan PP; Jones JV; Barnes K; Oerter-Klein K; Cutler GB
J Clin Endocrinol Metab; 1999 Jan; 84(1):44-9. PubMed ID: 9920060
[TBL] [Abstract][Full Text] [Related]
12. The association of obesity and hyperandrogenemia during the pubertal transition in girls: obesity as a potential factor in the genesis of postpubertal hyperandrogenism.
McCartney CR; Prendergast KA; Chhabra S; Eagleson CA; Yoo R; Chang RJ; Foster CM; Marshall JC
J Clin Endocrinol Metab; 2006 May; 91(5):1714-22. PubMed ID: 16492701
[TBL] [Abstract][Full Text] [Related]
13. Serum concentrations of type I and III procollagen propeptides in healthy children and girls with central precocious puberty during treatment with gonadotropin-releasing hormone analog and cyproterone acetate.
Hertel NT; Stoltenberg M; Juul A; Main KM; Müller J; Nielsen CT; Lorenzen I; Skakkebaek NE
J Clin Endocrinol Metab; 1993 Apr; 76(4):924-7. PubMed ID: 8473407
[TBL] [Abstract][Full Text] [Related]
14. Sex hormone-binding globulin and lipid profile in pubertal children.
Garcés C; Oya Id; Lasunción MA; López-Simón L; Cano B; de Oya M
Metabolism; 2010 Feb; 59(2):166-71. PubMed ID: 19765778
[TBL] [Abstract][Full Text] [Related]
15. Effects of combined gonadotropin-releasing hormone agonist and growth hormone therapy on adult height in precocious puberty: a further contribution.
Pucarelli I; Segni M; Ortore M; Arcadi E; Pasquino AM
J Pediatr Endocrinol Metab; 2003 Sep; 16(7):1005-10. PubMed ID: 14513877
[TBL] [Abstract][Full Text] [Related]
16. [Effects of obesity on peak level of luteinizing hormone in gonadotropin-releasing hormone agonist test and obesity-related hormones in girls with central precocious puberty].
Zhou XL; Fu JF; Jin JH; Dong GP; Jiang YJ; Huang K; Chen XF; Wu W
Zhongguo Dang Dai Er Ke Za Zhi; 2015 Aug; 17(8):763-8. PubMed ID: 26287335
[TBL] [Abstract][Full Text] [Related]
17. Effect of weight reduction on insulin sensitivity, sex hormone-binding globulin, sex hormones and gonadotrophins in obese children.
Birkebaek NH; Lange A; Holland-Fischer P; Kristensen K; Rittig S; Vilstrup H; Handberg A; Gronbaek H
Eur J Endocrinol; 2010 Dec; 163(6):895-900. PubMed ID: 20829367
[TBL] [Abstract][Full Text] [Related]
18. Prevention of bone demineralization by calcium supplementation in precocious puberty during gonadotropin-releasing hormone agonist treatment.
Antoniazzi F; Bertoldo F; Lauriola S; Sirpresi S; Gasperi E; Zamboni G; Tatò L
J Clin Endocrinol Metab; 1999 Jun; 84(6):1992-6. PubMed ID: 10372699
[TBL] [Abstract][Full Text] [Related]
19. Low serum allopregnanolone levels in girls with precocious pubarche.
Iughetti L; Predieri B; Luisi S; Casarosa E; Bernasconi S; Petraglia F
Steroids; 2005 Sep; 70(10):725-31. PubMed ID: 15893352
[TBL] [Abstract][Full Text] [Related]
20. Long-term observation of 87 girls with idiopathic central precocious puberty treated with gonadotropin-releasing hormone analogs: impact on adult height, body mass index, bone mineral content, and reproductive function.
Pasquino AM; Pucarelli I; Accardo F; Demiraj V; Segni M; Di Nardo R
J Clin Endocrinol Metab; 2008 Jan; 93(1):190-5. PubMed ID: 17940112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
